Advertisement
Screener

ARTIVION, INC. (AORT) Operating Income

ARTIVION, INC. Operating Income

ARTIVION, INC. (AORT) reported Operating Income of -$8.36 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.

Financial Statements › Income Statement

us-gaap:OperatingIncomeLoss · last filed 2026-08-07

  • ARTIVION, INC. operating income (loss) for the quarter ending 2026-06-30 was -$8.36M, a 199.76% decline year-over-year.
  • ARTIVION, INC. operating income (loss) for the quarter ending 2026-03-31 was $5.79M, a 169.79% increase year-over-year.
  • ARTIVION, INC. operating income (loss) for the quarter ending 2025-12-31 was $10.68M, a 300.15% increase year-over-year.
  • ARTIVION, INC. operating income (loss) for the quarter ending 2025-09-30 was $12.54M, a 185.75% increase year-over-year.
  • ARTIVION, INC. operating income (loss) for fiscal 2025 was $33.74M, a 13.19% decline from fiscal 2024.
  • ARTIVION, INC. operating income (loss) for fiscal 2024 was $38.87M, a 577.01% increase from fiscal 2023.
  • ARTIVION, INC. operating income (loss) for fiscal 2023 was $5.74M, a 7.40% decline from fiscal 2022.
  • ARTIVION, INC. operating income (loss) for fiscal 2022 was $6.20M, a 23.60% decline from fiscal 2021.
Period endOperating Income (Loss) 3 monthOperating Income (Loss) 3 month as first filedOperating Income (Loss) 6 monthOperating Income (Loss) 9 monthOperating Income (Loss) 12 month
2026-06-30-$8.36M
10-Q · filed 2026-08-07
-$2.58M
10-Q · filed 2026-08-07
$8.10M
derived: sum of 3 quarters · filed 2026-08-07
$20.64M
derived: sum of 4 quarters · filed 2026-08-07
2026-03-31$5.79M
10-Q · filed 2026-05-08
$16.47M
derived: sum of 2 quarters · filed 2026-05-08
$29.00M
derived: sum of 3 quarters · filed 2026-05-08
$37.39M
derived: sum of 4 quarters · filed 2026-08-07
2025-12-31$10.68M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18
$23.22M
derived: sum of 2 quarters · filed 2026-02-18
$31.60M
derived: sum of 3 quarters · filed 2026-08-07
$33.74M
10-K · filed 2026-02-18
2025-09-30$12.54M
10-Q · filed 2025-11-07
$20.92M
derived: sum of 2 quarters · filed 2026-08-07
$23.07M
10-Q · filed 2025-11-07
$25.73M
derived: sum of 4 quarters · filed 2026-08-07
2025-06-30$8.38M
10-Q · filed 2026-08-07
$10.53M
10-Q · filed 2026-08-07
$13.20M
derived: sum of 3 quarters · filed 2026-08-07
$17.59M
derived: sum of 4 quarters · filed 2026-08-07
2025-03-31$2.15M
10-Q · filed 2026-05-08
$4.81M
derived: sum of 2 quarters · filed 2026-05-08
$9.20M
derived: sum of 3 quarters · filed 2026-05-08
$15.71M
derived: sum of 4 quarters · filed 2026-05-08
2024-12-31$2.67M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18
$7.06M
derived: sum of 2 quarters · filed 2026-02-18
$13.56M
derived: sum of 3 quarters · filed 2026-02-18
$38.87M
10-K · filed 2026-02-18
2024-09-30$4.39M
10-Q · filed 2025-11-07
$10.89M
derived: sum of 2 quarters · filed 2025-11-07
$36.20M
10-Q · filed 2025-11-07
$39.38M
derived: sum of 4 quarters · filed 2026-02-18
2024-06-30$6.51M
10-Q · filed 2025-08-08
$31.82M
10-Q · filed 2025-08-08
$34.99M
derived: sum of 3 quarters · filed 2026-02-18
$33.75M
derived: sum of 4 quarters · filed 2026-02-18
2024-03-31$25.31M
10-Q · filed 2025-05-06
$28.48M
derived: sum of 2 quarters · filed 2026-02-18
$27.24M
derived: sum of 3 quarters · filed 2026-02-18
$34.91M
derived: sum of 4 quarters · filed 2026-02-18
2023-12-31$3.17M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18
$1.93M
derived: sum of 2 quarters · filed 2026-02-18
$9.60M
derived: sum of 3 quarters · filed 2026-02-18
$5.74M
10-K · filed 2026-02-18
2023-09-30-$1.24M
10-Q · filed 2024-11-08
$6.43M
derived: sum of 2 quarters · filed 2024-11-08
$2.57M
10-Q · filed 2024-11-08
$6.70M
derived: sum of 4 quarters · filed 2025-02-28
2023-06-30$7.67M
10-Q · filed 2024-08-09
$3.81M
10-Q · filed 2024-08-09
$7.94M
derived: sum of 3 quarters · filed 2025-02-28
$3.84M
derived: sum of 4 quarters · filed 2025-02-28
2023-03-31-$3.86M
10-Q · filed 2024-05-07
$269.00K
derived: sum of 2 quarters · filed 2025-02-28
-$3.84M
derived: sum of 3 quarters · filed 2025-02-28
$704.00K
derived: sum of 4 quarters · filed 2025-02-28
2022-12-31$4.13M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28
$24.00K
derived: sum of 2 quarters · filed 2025-02-28
$4.57M
derived: sum of 3 quarters · filed 2025-02-28
$6.20M
10-K · filed 2025-02-28
2022-09-30-$4.11M
10-Q · filed 2023-11-03
$435.00K
derived: sum of 2 quarters · filed 2023-11-03
$2.07M
10-Q · filed 2023-11-03
-$7.27M
derived: sum of 4 quarters · filed 2024-02-23
2022-06-30$4.54M
10-Q · filed 2023-08-04
$6.18M
10-Q · filed 2023-08-04
-$3.16M
derived: sum of 3 quarters · filed 2024-02-23
$11.53M
derived: sum of 4 quarters · filed 2024-02-23
2022-03-31$1.64M
10-Q · filed 2023-05-05
-$7.70M
derived: sum of 2 quarters · filed 2024-02-23
$6.98M
derived: sum of 3 quarters · filed 2024-02-23
$8.31M
derived: sum of 4 quarters · filed 2024-02-23
2021-12-31-$9.34M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23
$5.35M
derived: sum of 2 quarters · filed 2024-02-23
$6.67M
derived: sum of 3 quarters · filed 2024-02-23
$8.12M
10-K · filed 2024-02-23
2021-09-30$14.69M
10-Q · filed 2022-11-04
$16.01M
derived: sum of 2 quarters · filed 2022-11-04
$17.46M
10-Q · filed 2022-11-04
$19.37M
derived: sum of 4 quarters · filed 2023-02-23
2021-06-30$1.32M
10-Q · filed 2022-08-05
$2.77M
10-Q · filed 2022-08-05
$4.68M
derived: sum of 3 quarters · filed 2023-02-23
$8.32M
derived: sum of 4 quarters · filed 2023-02-23
2021-03-31$1.45M
10-Q · filed 2022-05-06
$3.36M
derived: sum of 2 quarters · filed 2023-02-23
$6.99M
derived: sum of 3 quarters · filed 2023-02-23
$5.07M
derived: sum of 4 quarters · filed 2023-02-23
2020-12-31$1.91M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23
$5.55M
derived: sum of 2 quarters · filed 2023-02-23
$3.63M
derived: sum of 3 quarters · filed 2023-02-23
$2.44M
10-K · filed 2023-02-23
2020-09-30$3.63M
10-Q · filed 2021-11-05
$1.71M
derived: sum of 2 quarters · filed 2021-11-05
$527.00K
10-Q · filed 2021-11-05
$4.16M
derived: sum of 4 quarters · filed 2022-02-22
2020-06-30-$1.92M
10-Q · filed 2021-07-30
-$3.11M
10-Q · filed 2021-07-30
$524.00K
derived: sum of 3 quarters · filed 2022-02-22
$5.23M
derived: sum of 4 quarters · filed 2022-02-22
2020-03-31-$1.19M
10-Q · filed 2021-04-30
$2.44M
derived: sum of 2 quarters · filed 2022-02-22
$7.15M
derived: sum of 3 quarters · filed 2022-02-22
$13.65M
derived: sum of 4 quarters · filed 2022-02-22
2019-12-31$3.63M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22
$8.34M
derived: sum of 2 quarters · filed 2022-02-22
$14.84M
derived: sum of 3 quarters · filed 2022-02-22
$17.04M
10-K · filed 2022-02-22
2019-09-30$4.70M
10-Q · filed 2020-11-05
$11.21M
derived: sum of 2 quarters · filed 2020-11-05
$13.41M
10-Q · filed 2020-11-05
$16.19M
derived: sum of 4 quarters · filed 2021-02-23
2019-06-30$6.50M
10-Q · filed 2020-07-31
$8.71M
10-Q · filed 2020-07-31
$11.49M
derived: sum of 3 quarters · filed 2021-02-23
$16.10M
derived: sum of 4 quarters · filed 2021-02-23
2019-03-31$2.21M
10-Q · filed 2020-05-01
$4.98M
derived: sum of 2 quarters · filed 2021-02-23
$9.60M
derived: sum of 3 quarters · filed 2021-02-23
$15.01M
derived: sum of 4 quarters · filed 2021-02-23
2018-12-31$2.78M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23
$7.40M
derived: sum of 2 quarters · filed 2021-02-23
$12.80M
derived: sum of 3 quarters · filed 2021-02-23
$9.31M
10-K · filed 2021-02-23
2018-09-30$4.62M
10-Q · filed 2019-10-31
$10.02M
derived: sum of 2 quarters · filed 2019-10-31
$6.53M
10-Q · filed 2019-10-31
$6.34M
derived: sum of 4 quarters · filed 2020-02-19
2018-06-30$5.41M
10-Q · filed 2019-07-31
$1.92M
10-Q · filed 2019-07-31
$1.72M
derived: sum of 3 quarters · filed 2020-02-19
$2.55M
derived: sum of 4 quarters · filed 2020-02-19
2018-03-31-$3.49M
10-Q · filed 2019-05-02
-$3.69M
derived: sum of 2 quarters · filed 2020-02-19
-$2.86M
derived: sum of 3 quarters · filed 2020-02-19
$1.93M
derived: sum of 4 quarters · filed 2020-02-19
2017-12-31-$195.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19
$634.00K
derived: sum of 2 quarters · filed 2020-02-19
$5.42M
derived: sum of 3 quarters · filed 2020-02-19
$7.97M
10-K · filed 2020-02-19
2017-09-30$829.00K
10-Q · filed 2018-11-01
$5.62M
derived: sum of 2 quarters · filed 2018-11-01
$8.16M
10-Q · filed 2018-11-01
$13.27M
derived: sum of 4 quarters · filed 2019-02-26
2017-06-30$4.79M
10-Q · filed 2018-08-07
$7.34M
10-Q · filed 2018-08-07
$12.44M
derived: sum of 3 quarters · filed 2019-02-26
$17.92M
derived: sum of 4 quarters · filed 2019-02-26
2017-03-31$2.55M
10-Q · filed 2018-05-04
$7.65M
derived: sum of 2 quarters · filed 2019-02-26
$13.13M
derived: sum of 3 quarters · filed 2019-02-26
$17.71M
derived: sum of 4 quarters · filed 2019-02-26
2016-12-31$5.11M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26
$10.58M
derived: sum of 2 quarters · filed 2019-02-26
$15.17M
derived: sum of 3 quarters · filed 2019-02-26
$21.82M
10-K · filed 2019-02-26
2016-09-30$5.48M
10-Q · filed 2017-10-31
$10.06M
derived: sum of 2 quarters · filed 2017-10-31
$16.71M
10-Q · filed 2017-10-31
$21.55M
derived: sum of 4 quarters · filed 2018-03-09
2016-06-30$4.59M
10-Q · filed 2017-07-25
$11.24M
10-Q · filed 2017-07-25
$16.08M
derived: sum of 3 quarters · filed 2018-03-09
$18.60M
derived: sum of 4 quarters · filed 2018-03-09
2016-03-31$6.65M
10-Q · filed 2017-04-27
$11.49M
derived: sum of 2 quarters · filed 2018-03-09
$14.02M
derived: sum of 3 quarters · filed 2018-03-09
$13.56M
derived: sum of 4 quarters · filed 2018-03-09
2015-12-31$4.84M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09
$7.37M
derived: sum of 2 quarters · filed 2018-03-09
$6.91M
derived: sum of 3 quarters · filed 2018-03-09
$5.35M
10-K · filed 2018-03-09
2015-09-30$2.53M
10-Q · filed 2016-10-27
$2.07M
derived: sum of 2 quarters · filed 2016-10-27
$517.00K
10-Q · filed 2016-10-27
$2.42M
derived: sum of 4 quarters · filed 2017-02-16
2015-06-30-$457.00K
10-Q · filed 2016-07-26
-$2.01M
10-Q · filed 2016-07-26
-$106.00K
derived: sum of 3 quarters · filed 2017-02-16
$2.91M
derived: sum of 4 quarters · filed 2017-02-16
2015-03-31-$1.55M
10-Q · filed 2016-04-29
$351.00K
derived: sum of 2 quarters · filed 2017-02-16
$3.37M
derived: sum of 3 quarters · filed 2017-02-16
$5.59M
derived: sum of 4 quarters · filed 2017-02-16
2014-12-31$1.91M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16
$4.92M
derived: sum of 2 quarters · filed 2017-02-16
$7.14M
derived: sum of 3 quarters · filed 2017-02-16
$8.84M
10-K · filed 2017-02-16
2014-09-30$3.02M
10-Q · filed 2015-10-27
$5.24M
derived: sum of 2 quarters · filed 2015-10-27
$6.93M
10-Q · filed 2015-10-27
$10.07M
derived: sum of 4 quarters · filed 2016-02-16
2014-06-30$2.22M
10-Q · filed 2015-07-28
$3.92M
10-Q · filed 2015-07-28
$7.05M
derived: sum of 3 quarters · filed 2016-02-16
$11.62M
derived: sum of 4 quarters · filed 2016-02-16
2014-03-31$1.70M
10-Q · filed 2015-04-29
$4.83M
derived: sum of 2 quarters · filed 2016-02-16
$9.39M
derived: sum of 3 quarters · filed 2016-02-16
$12.21M
derived: sum of 4 quarters · filed 2016-02-16
2013-12-31$3.13M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-16
$7.70M
derived: sum of 2 quarters · filed 2016-02-16
$10.51M
derived: sum of 3 quarters · filed 2016-02-16
$13.82M
10-K · filed 2016-02-16
2013-09-30$4.57M
10-Q · filed 2014-10-28
$7.38M
derived: sum of 2 quarters · filed 2014-10-28
$10.69M
10-Q · filed 2014-10-28
$12.77M
derived: sum of 4 quarters · filed 2014-10-28
2013-06-30$2.81M
10-Q · filed 2014-07-24
$6.12M
10-Q · filed 2014-07-24
$8.21M
derived: sum of 3 quarters · filed 2014-07-24
$11.15M
derived: sum of 4 quarters · filed 2014-07-24
2013-03-31$3.31M
10-Q · filed 2014-04-30
$5.39M
derived: sum of 2 quarters · filed 2014-04-30
$8.34M
derived: sum of 3 quarters · filed 2014-04-30
$14.17M
derived: sum of 4 quarters · filed 2014-04-30
2012-12-31$2.08M
10-K · filed 2013-02-15
$5.03M
derived: sum of 2 quarters · filed 2013-10-29
$10.86M
derived: sum of 3 quarters · filed 2013-10-29
$12.61M
10-K · filed 2015-02-17
2012-09-30$2.95M
10-Q · filed 2013-10-29
$8.78M
derived: sum of 2 quarters · filed 2013-10-29
$10.41M
10-Q · filed 2013-10-29
$12.27M
derived: sum of 4 quarters · filed 2013-10-29
2012-06-30$5.83M
10-Q · filed 2013-07-25
$7.46M
10-Q · filed 2013-07-25
$9.32M
derived: sum of 3 quarters · filed 2013-07-25
$11.34M
derived: sum of 4 quarters · filed 2013-07-25
2012-03-31$1.63M
10-Q · filed 2013-04-30
$3.50M
derived: sum of 2 quarters · filed 2013-04-30
$5.51M
derived: sum of 3 quarters · filed 2013-04-30
$7.33M
derived: sum of 4 quarters · filed 2013-04-30
2011-12-31$1.87M
10-K · filed 2013-02-15
$3.88M
derived: sum of 2 quarters · filed 2013-02-15
$5.71M
derived: sum of 3 quarters · filed 2013-02-15
$11.64M
10-K · filed 2014-02-21
2011-09-30$2.02M
10-K · filed 2013-02-15
$2.50M
10-Q · filed 2011-10-27
$3.84M
derived: sum of 2 quarters · filed 2013-02-15
$8.69M
10-Q · filed 2012-10-30
$7.62M
derived: sum of 4 quarters · filed 2013-02-15
2011-06-30$1.82M
10-K · filed 2013-02-15
$3.75M
10-Q · filed 2011-07-29
$6.20M
10-Q · filed 2012-07-31
$5.60M
derived: sum of 3 quarters · filed 2013-02-15
$2.57M
derived: sum of 4 quarters · filed 2013-02-15
2011-03-31$1.67M
10-K · filed 2013-02-15
$2.45M
10-Q · filed 2012-04-26
$3.78M
derived: sum of 2 quarters · filed 2013-02-15
$750.00K
derived: sum of 3 quarters · filed 2013-02-15
$3.68M
derived: sum of 4 quarters · filed 2013-02-15
2010-12-31$2.12M
10-K · filed 2013-02-15
-$916.00K
derived: sum of 2 quarters · filed 2013-02-15
$2.01M
derived: sum of 3 quarters · filed 2013-02-15
$9.87M
10-K · filed 2013-02-15
2010-09-30-$3.03M
10-K · filed 2013-02-15
-$1.26M
10-Q · filed 2011-10-27
-$105.00K
derived: sum of 2 quarters · filed 2013-02-15
$6.29M
10-Q · filed 2011-10-27
2010-06-30$2.93M
10-K · filed 2013-02-15
$4.86M
10-Q · filed 2011-07-29
$7.54M
10-Q · filed 2011-07-29
2010-03-31$1.93M
10-K · filed 2013-02-15
2009-12-31$14.50M
10-K · filed 2012-02-17

Similar stocks

Stock NameCountryMarket CapPE Ratio
IRADIMED CORP (IRMD)United States$1.089B52.92
TANDEM DIABETES CARE INC (TNDM)United States$1.059B-16.57
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)United States$1.234B-193.02
PROCEPT BioRobotics Corp (PRCT)United States$1.001B-11.77
Beta Bionics, Inc. (BBNX)United States$0.979B-9.66
SpyGlass Pharma, Inc. (SGP)United States$0.925B
SI-BONE, Inc. (SIBN)United States$0.830B-49.82
Alphatec Holdings, Inc. (ATEC)United States$1.531B-12.14
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)United States$1.535B-9.02
MIMEDX GROUP, INC. (MDXG)United States$0.687B89.92